Jefferies Reiterates Hold Following Oracle (ORCL) F4Q Miss

Total Cloud Revenues Up 28% but Would Have Been Up 34% in Constant Currency

REDWOOD SHORES, CA -- (Marketwired) -- 06/17/15 -- Oracle Corporation (NYSE: ORCL) today announced fiscal 2015 Q4 results. The results were significantly impacted by the strengthening of the U.S. dollar compared to foreign currencies. Total Q4 Revenues were $10.7 billion, down 5% but would have been up 3% without the strengthening of the U.S. dollar. Software and Cloud Revenues were $8.4 billion, down 6%, but up 2% in constant currency. Cloud software as a service (SaaS) and platform as a service (PaaS) revenues were $416 million, growing 29%, and up 35% in constant currency. Cloud infrastructure as a service (IaaS) revenues were $160 million,... More

Oracle Health Sciences InForm Cloud Service 6.1 Helps Life Sciences Organizations Accelerate Study Start-Up and Expand Risk-Based Monitoring Precision

WASHINGTON, DC -- (Marketwired) -- 06/16/15 -- DIA 2015 -- Oracle Health Sciences (NYSE: ORCL) today announced the availability of Oracle Health Sciences InForm Cloud Service 6.1. The latest release of the Oracle Health Sciences InForm data capture and management platform provides trial sponsors and contract research organizations (CROs) with a complete, integrated solution designed to accelerate trial timelines, lower costs, deliver higher data quality, and reduce... More

Oracle Expands Clinical Safety Monitoring and Reporting Capabilities With Oracle Argus 8.0 Solutions

WASHINGTON, DC -- (Marketwired) -- 06/16/15 -- DIA 2015 -- Oracle (NYSE: ORCL) -- Oracle Health Sciences today announced the availability of Oracle Argus Standard Edition 8.0, Oracle Argus Enterprise Edition 8.0, and Oracle Argus Safety Japan 8.0 -- major new Oracle Argus releases for sponsors and manufacturers of pharmaceuticals, medical devices, and vaccines, as well as contract research organizations and health authorities.

This latest release of Oracle's... More